参考文献/References:
[1] Kuwahara G, Tashiro T. Current status of off-pump coronary artery bypass [J]. Annals of Thoracic and Cardiovascular Surgery, 2020, 26 (3): 125.
[2] Ofoegbu C K, Manganyi R M. Off-pump coronary artery bypass grafting; is it still relevant?[J]. Current Cardiology Reviews, 2022, 18 (2): 64-77.
[3] Shaefi S, Mittel A, Loberman D, et al. Off-pump versus on-pump coronary artery bypass grafting—a systematic review and analysis of clinical outcomes [J]. Journal of cardiothoracic and vascular anesthesia, 2019, 33 (1): 232-244.
[4] Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks [J]. Genome Res, 2003, 13 (11): 2498-2504.
[5] Gerola L R, Buffolo E, Jasbik W, et al. Off-pump versus on-pump myocardial revascularization in low-risk patients with one or two vessel disease: perioperative results in a multicenter randomized controlled trial [J]. The Annals of Thoracic Surgery, 2004, 77 (2): 569-573.
[6] Shroyer A L, Grover F L, Hattler B, et al. On-pump versus off-pump coronary-artery bypass surgery [J]. New England Journal of Medicine, 2009, 361 (19): 1827-1837.
[7] Wan I Y, Arifi A A, Wan S, et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study [J]. J Thorac Cardiovasc Surg, 2004, 127 (6): 1624-1631.
[8] Urbanowicz T, Michalak M, Gasecka A, et al. Postoperative neutrophil to lymphocyte ratio as an overall mortality midterm prognostic factor following OPCAB Procedures [J]. Clin Pract, 2021, 11 (3): 587-597.
[9] Urbanowicz T, Michalak M, Olasińska-Wisniewska A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and systemic inflammatory response index (SIRI) predict mortality after off-pump coronary artery bypass surgery [J]. Cells, 2022, 11 (7): 1124.
[10] Parlar H, H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG[BF]?[BFQ][J]. Brazilian Journal of Cardiovascular Surgery, 2018, 33: 233-241.
[11] Palomer X, Román-Azcona M S, Pizarro-Delgado J, et al. SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation [J]. Signal transduction and targeted therapy, 2020, 5 (1): 1-10.
[12] Liu Y, Wu F, Wu Y, et al. Mechanism of IL-6-related spontaneous atrial fibrillation after coronary artery grafting surgery: IL-6 knockout mouse study and human observation [J]. Translational Research, 2021, 233: 16-31.
[13] Billah M, Ridiandries A, Rayner B, et al. Egr-1 functions as a master switch regulator of remote ischemic preconditioning-induced cardioprotection [J]. Basic Research in Cardiology, 2020, 115 (1): 1-20.
[14] 周宁, 张魁, 乔博康, 等. 活化转录因子3在再狭窄静脉桥血管中的表达 [J]. 中国医药, 2018, 13(5): 773-776.